Genesys Spine Launches Sacroiliac Joint Fusion System

Genesys Spine has announced the launch of the Genesys Spine Sacroiliac Joint Fusion System which consists of partially threaded and fully threaded implants designed to secure the sacroiliac joint and minimize micro-motion enabling bony fusion.

  • Dual thread designs incorporate a differential pitch for controlled compression across the joint.
  • Cannulated design allows for minimally invasive placement.
  • Offered in fully threaded and dual threaded configurations.
  • Optional washers designed to maximize purchase on the ilium without burying the implant head in the bone.
  • Increased surface roughness to help facilitate osteoinduction.
  • Rifled inner diameter to reduce inadvertent targeting pin migration.

“The Genesys Spine SI Fusion System is a game-changer. It provides one streamlined system that addresses the pathology of sacroiliitis in both the lateral and posterior approaches. Many SI pain patients are mis underdiagnosed due to their pain mimicking low back pain. This system will deliver health care providers with versatile tools to treat these patients in need of an SI Joint Fusion.”

-Dr. Kaywan Gamadia, DO Cape Spine & Neurosurgery Cape Girardeau, MO

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version